NO874704D0 - Minaktivin fremstilt ved rekombinant dna-teknikk. - Google Patents
Minaktivin fremstilt ved rekombinant dna-teknikk.Info
- Publication number
- NO874704D0 NO874704D0 NO1987874704A NO874704A NO874704D0 NO 874704 D0 NO874704 D0 NO 874704D0 NO 1987874704 A NO1987874704 A NO 1987874704A NO 874704 A NO874704 A NO 874704A NO 874704 D0 NO874704 D0 NO 874704D0
- Authority
- NO
- Norway
- Prior art keywords
- minactivin
- recombinant dna
- dna technology
- manufactured
- purification
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8132—Plasminogen activator inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/972—Plasminogen activators
- G01N2333/9723—Urokinase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO952506A NO952506L (no) | 1986-03-13 | 1995-06-22 | Antistoffpreparater mot homogent minaktivin og anvendelse derav for påvisning av minaktivin i humane kroppsvæsker |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPH501786 | 1986-03-13 | ||
AUPH603386 | 1986-05-22 | ||
AUPH810086 | 1986-09-18 | ||
AUPH910486 | 1986-11-21 | ||
PCT/AU1987/000068 WO1987005628A1 (en) | 1986-03-13 | 1987-03-13 | Minactivin produced by recombinant dna technology |
Publications (4)
Publication Number | Publication Date |
---|---|
NO874704L NO874704L (no) | 1987-11-11 |
NO874704D0 true NO874704D0 (no) | 1987-11-11 |
NO178504B NO178504B (no) | 1996-01-02 |
NO178504C NO178504C (no) | 1996-04-10 |
Family
ID=27424177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO874704A NO178504C (no) | 1986-03-13 | 1987-11-11 | Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat |
Country Status (13)
Country | Link |
---|---|
US (1) | US5426044A (no) |
EP (1) | EP0238275B1 (no) |
JP (2) | JP2589996B2 (no) |
KR (1) | KR960001820B1 (no) |
CN (2) | CN1032019C (no) |
AT (1) | ATE132192T1 (no) |
CA (1) | CA1338381C (no) |
DE (1) | DE3751646T2 (no) |
DK (2) | DK172400B1 (no) |
IL (1) | IL81879A (no) |
NO (1) | NO178504C (no) |
NZ (1) | NZ219608A (no) |
WO (1) | WO1987005628A1 (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4923807A (en) * | 1984-05-18 | 1990-05-08 | New England Medical Center Hospitals Inc. | Arg-Serpin human plasminogen activator inhibitor designated PAI-2 |
JPH04502108A (ja) * | 1989-09-05 | 1992-04-16 | バイオテクノロジー オーストラリア ピーティーワイ リミテッド | 組替え生産物 |
US5444153A (en) * | 1989-12-20 | 1995-08-22 | Biotech Australia Pty Limited | Variants of PAI-2 |
GB9026737D0 (en) * | 1990-12-08 | 1991-01-30 | Delta Biotechnology Ltd | Cancer treatment |
US5994309A (en) | 1997-07-25 | 1999-11-30 | Angstrom Pharmaceuticals, Inc. | Anti-invasive and anti-angiogenic compositions and methods |
CN102586187A (zh) * | 2012-02-23 | 2012-07-18 | 深圳市中美康士生物科技有限公司 | 一种中性粒细胞体外保存方法及培养基 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4923807A (en) * | 1984-05-18 | 1990-05-08 | New England Medical Center Hospitals Inc. | Arg-Serpin human plasminogen activator inhibitor designated PAI-2 |
WO1986001212A1 (en) * | 1984-08-13 | 1986-02-27 | Biotechnology Australia Pty. Ltd. | Minactivin |
CA1331355C (en) * | 1986-04-21 | 1994-08-09 | Bioenterprises Pty. Ltd | Immunopotentation |
-
1987
- 1987-03-12 IL IL8187987A patent/IL81879A/en not_active IP Right Cessation
- 1987-03-13 AT AT87302200T patent/ATE132192T1/de not_active IP Right Cessation
- 1987-03-13 CN CN87102725A patent/CN1032019C/zh not_active Expired - Fee Related
- 1987-03-13 NZ NZ219608A patent/NZ219608A/en unknown
- 1987-03-13 WO PCT/AU1987/000068 patent/WO1987005628A1/en unknown
- 1987-03-13 JP JP62501852A patent/JP2589996B2/ja not_active Expired - Fee Related
- 1987-03-13 CA CA000531981A patent/CA1338381C/en not_active Expired - Fee Related
- 1987-03-13 DE DE3751646T patent/DE3751646T2/de not_active Expired - Fee Related
- 1987-03-13 EP EP87302200A patent/EP0238275B1/en not_active Expired - Lifetime
- 1987-03-13 KR KR1019870701038A patent/KR960001820B1/ko not_active IP Right Cessation
- 1987-11-11 NO NO874704A patent/NO178504C/no not_active IP Right Cessation
- 1987-11-13 DK DK595187A patent/DK172400B1/da not_active IP Right Cessation
-
1991
- 1991-04-30 US US07/693,636 patent/US5426044A/en not_active Expired - Lifetime
-
1994
- 1994-05-21 CN CN94105143A patent/CN1100957A/zh active Pending
-
1995
- 1995-05-29 JP JP7153825A patent/JP2660681B2/ja not_active Expired - Fee Related
-
1997
- 1997-03-13 DK DK027097A patent/DK27097A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK595187A (da) | 1988-07-21 |
KR880701073A (ko) | 1988-07-25 |
WO1987005628A1 (en) | 1987-09-24 |
US5426044A (en) | 1995-06-20 |
JPS63503354A (ja) | 1988-12-08 |
DE3751646D1 (de) | 1996-02-08 |
DK595187D0 (da) | 1987-11-13 |
DK172400B1 (da) | 1998-05-18 |
EP0238275B1 (en) | 1995-12-27 |
DE3751646T2 (de) | 1996-10-17 |
NO178504B (no) | 1996-01-02 |
NO874704L (no) | 1987-11-11 |
CN87102725A (zh) | 1987-11-11 |
JP2660681B2 (ja) | 1997-10-08 |
JPH08112094A (ja) | 1996-05-07 |
JP2589996B2 (ja) | 1997-03-12 |
ATE132192T1 (de) | 1996-01-15 |
CN1100957A (zh) | 1995-04-05 |
EP0238275A2 (en) | 1987-09-23 |
IL81879A (en) | 1994-07-31 |
NZ219608A (en) | 1991-05-28 |
NO178504C (no) | 1996-04-10 |
KR960001820B1 (ko) | 1996-02-05 |
EP0238275A3 (en) | 1989-05-10 |
CA1338381C (en) | 1996-06-11 |
CN1032019C (zh) | 1996-06-12 |
DK27097A (da) | 1997-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI100056B (fi) | Ihmisproapolipoproteiinin A-I ilmaiseminen | |
RU95115239A (ru) | Аналог эритропоэтина | |
FI953658A0 (fi) | Stabiileja bakterisidisia/läpäisevyyttä parantavia proteiinituotteita ja näitä sisältäviä farmaseuttisia koostumuksia | |
DE3650645D1 (de) | Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose | |
ATE380867T1 (de) | Lactoferrinrezeptorgen von moraxella | |
ATE91722T1 (de) | Pferde-gamma-interferon. | |
ATE121776T1 (de) | Expression des biologisch aktiven faktors xiii. | |
ATE338113T1 (de) | Transferrin-rezeptor gene von haemophilus | |
DE69737766D1 (de) | Zusammensetzungen von stammzellfaktor (scf)-analogen und auf diese bezogene verfahren | |
NO874704L (no) | Minaktivin fremstilt ved rekombinant dna-teknikk. | |
ATE163651T1 (de) | Neues menschliches, rekombinantes interferon gamma | |
NO930428D0 (no) | Proteinstrukturen til plantetoksingelonin | |
EP0261403A3 (de) | Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle | |
ES2124694T3 (es) | Clonacion de la n-metil-hidantoinasa. | |
DE602004019556D1 (de) | Neues plexin-polypeptid, dieses codierende dna und verwendung davon | |
TH5997EX (th) | การสร้างโปรอโปดิโปรโปรตีน a-i ของคนโดยการแสดงออกของรหัสพันธุกรรม |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN SEPTEMBER 2002 |